These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44 related articles for article (PubMed ID: 1966960)
1. The heritage of radiotracers for positron emission tomography. Fowler JS; Wolf AP Acta Radiol Suppl; 1990; 374():13-6. PubMed ID: 1966960 [TBL] [Abstract][Full Text] [Related]
2. The evolution of positron emission tomography. Tilyou SM J Nucl Med; 1991 Apr; 32(4):15N-19N, 23N-26N. PubMed ID: 2013789 [No Abstract] [Full Text] [Related]
3. Proceedings of a National Cancer Institute workshop: PET in oncology--a clinical research agenda. Wahl RL; Hawkins RA; Larson SM; Hendee WR; Coleman RE; Holden RW; Frick MP; Gatsonis C; Brown GS; Shtern F Radiology; 1994 Dec; 193(3):604-6. PubMed ID: 7972793 [No Abstract] [Full Text] [Related]
4. [Three-dimensional positron emission tomography imaging system and its application for medical use]. Orihara H; Ishii K; Iwata R; Fujiwara T; Itoh M Nihon Rinsho; 1997 Aug; 55(8):2148-55. PubMed ID: 9284437 [TBL] [Abstract][Full Text] [Related]
7. Pharmacology and pharmacokinetics of stereoisomers in radiopharmacy. Cohen Y; Besnard M; Merlin L Acta Radiol Suppl; 1990; 374():25-32. PubMed ID: 1966966 [TBL] [Abstract][Full Text] [Related]
8. Update on PET radiopharmaceuticals: life beyond fluorodeoxyglucose. Shiue CY; Welch MJ Radiol Clin North Am; 2004 Nov; 42(6):1033-53, viii. PubMed ID: 15488556 [TBL] [Abstract][Full Text] [Related]
9. [Potential use of positron-emission tomography in clinical oncology]. Fukuda H; Matsuzawa T; Tateno Y Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):860-5. PubMed ID: 3291774 [TBL] [Abstract][Full Text] [Related]
10. Neuroimaging in epilepsy: is there a future for positron emission tomography. Sadzot B Epilepsia; 1996 Jun; 37(6):511-4. PubMed ID: 8641225 [No Abstract] [Full Text] [Related]
11. Special characteristics and potential for radiotracers for positron emission tomography. Fowler JS; Wolf AP Acupunct Electrother Res; 1981; 6(2-3):81-108. PubMed ID: 6120624 [No Abstract] [Full Text] [Related]
12. [Clinical applications of positron emission tomography]. Goldman S Rev Med Brux; 1993; 14(1-2):3-9. PubMed ID: 8438112 [TBL] [Abstract][Full Text] [Related]
13. Radiopharmaceuticals for positron emission tomography. Development of new, innovative tracers for measuring the rates of physiologic and biochemical processes. Gatley SJ; DeGrado TR; Kornguth ML; Holden JE Acta Radiol Suppl; 1990; 374():7-11. PubMed ID: 1966972 [TBL] [Abstract][Full Text] [Related]
14. [Assessment of myocardial energy metabolism with PET]. Kinoshita S; Serizawa T Nihon Rinsho; 1997 Mar; 55 Suppl 1():644-7. PubMed ID: 9097693 [No Abstract] [Full Text] [Related]
15. Introduction to imaging brain tumor metabolism with positron emission tomography (PET). Conti PS Cancer Invest; 1995; 13(2):244-59. PubMed ID: 7874578 [TBL] [Abstract][Full Text] [Related]
16. Pancreatic tumors: imaging with PET. Hawkins RA Radiology; 1995 May; 195(2):320-2. PubMed ID: 7724745 [No Abstract] [Full Text] [Related]
18. [Positron emission tomography of the brain. A diagnostic technic on the threshold of clinical use]. Heiss WD Dtsch Med Wochenschr; 1983 Jun; 108(23):887-90. PubMed ID: 6602042 [No Abstract] [Full Text] [Related]
19. Is there a future for PET in oncology? Price P Eur J Nucl Med; 1997 Jun; 24(6):587-9. PubMed ID: 9235296 [No Abstract] [Full Text] [Related]